Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

AAD-2004 Attenuates Progressive Neuronal Loss in the Brain of Tg-betaCTF99/B6 Mouse Model of Alzheimer Disease.

Baek IS, Kim TK, Seo JS, Lee KW, Lee YA, Cho J, Gwag BJ, Han PL.

Exp Neurobiol. 2013 Mar;22(1):31-7. doi: 10.5607/en.2013.22.1.31. Epub 2013 Mar 31.

2.

Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein.

Lee KW, Im JY, Song JS, Lee SH, Lee HJ, Ha HY, Koh JY, Gwag BJ, Yang SD, Paik SG, Han PL.

Neurobiol Dis. 2006 Apr;22(1):10-24. Epub 2005 Nov 11.

PMID:
16289866
3.
4.

Involvement of brain oxidation in the cognitive impairment in a triple transgenic mouse model of Alzheimer's disease: noninvasive measurement of the brain redox state by magnetic resonance imaging.

Ishihara Y, Itoh K, Mitsuda Y, Shimada T, Kubota T, Kato C, Song SY, Kobayashi Y, Mori-Yasumoto K, Sekita S, Kirino Y, Yamazaki T, Shimamoto N.

Free Radic Res. 2013 Sep;47(9):731-9. doi: 10.3109/10715762.2013.818218. Epub 2013 Jul 15.

PMID:
23789828
5.

Severe motor neuron degeneration in the spinal cord of the Tg2576 mouse model of Alzheimer disease.

Seo JS, Leem YH, Lee KW, Kim SW, Lee JK, Han PL.

J Alzheimers Dis. 2010;21(1):263-76. doi: 10.3233/JAD-2010-091528.

PMID:
20421695
6.

Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's disease.

Zhang C, Rodriguez C, Spaulding J, Aw TY, Feng J.

J Alzheimers Dis. 2012;28(3):655-66. doi: 10.3233/JAD-2011-111244.

7.

Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model.

Li W, Yu J, Liu Y, Huang X, Abumaria N, Zhu Y, Huang X, Xiong W, Ren C, Liu XG, Chui D, Liu G.

J Neurosci. 2013 May 8;33(19):8423-41. doi: 10.1523/JNEUROSCI.4610-12.2013. Retraction in: J Neurosci. 2014 Apr 16;34(16):5733.

8.

Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.

Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D.

J Neurosci. 1996 Sep 15;16(18):5795-811.

9.

Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease.

Um HS, Kang EB, Koo JH, Kim HT, Jin-Lee, Kim EJ, Yang CH, An GY, Cho IH, Cho JY.

Neurosci Res. 2011 Feb;69(2):161-73. doi: 10.1016/j.neures.2010.10.004. Epub 2010 Oct 20.

PMID:
20969897
10.

All-trans retinoic acid improved impaired proliferation of neural stem cells and suppressed microglial activation in the hippocampus in an Alzheimer's mouse model.

Takamura R, Watamura N, Nikkuni M, Ohshima T.

J Neurosci Res. 2017 Mar;95(3):897-906. doi: 10.1002/jnr.23843. Epub 2016 Jul 22.

PMID:
27448243
11.

Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive function.

Kim TK, Han HE, Kim H, Lee JE, Choi D, Park WJ, Han PL.

Exp Mol Med. 2012 Dec 31;44(12):740-8. doi: 10.3858/emm.2012.44.12.082.

12.

Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.

Yin T, Yang L, Liu Y, Zhou X, Sun J, Liu J.

Acta Biomater. 2015 Oct;25:172-83. doi: 10.1016/j.actbio.2015.06.035. Epub 2015 Jul 2.

PMID:
26143603
13.

The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.

Kuo YM, Beach TG, Sue LI, Scott S, Layne KJ, Kokjohn TA, Kalback WM, Luehrs DC, Vishnivetskaya TA, Abramowski D, Sturchler-Pierrat C, Staufenbiel M, Weller RO, Roher AE.

Mol Med. 2001 Sep;7(9):609-18.

15.

Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis.

Shin JH, Lee YA, Lee JK, Lee YB, Cho W, Im DS, Lee JH, Yun BS, Springer JE, Gwag BJ.

J Neurochem. 2012 Sep;122(5):952-61. doi: 10.1111/j.1471-4159.2012.07771.x. Epub 2012 May 23.

16.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
17.

Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.

Isopi E, Granzotto A, Corona C, Bomba M, Ciavardelli D, Curcio M, Canzoniero LM, Navarra R, Lattanzio R, Piantelli M, Sensi SL.

Neurobiol Dis. 2015 Sep;81:214-24. doi: 10.1016/j.nbd.2014.11.013. Epub 2014 Nov 28.

PMID:
25434488
18.

Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease.

Rodríguez JJ, Jones VC, Tabuchi M, Allan SM, Knight EM, LaFerla FM, Oddo S, Verkhratsky A.

PLoS One. 2008 Aug 13;3(8):e2935. doi: 10.1371/journal.pone.0002935.

19.
20.

Immunity and neuronal repair in the progression of Alzheimer's disease: a brief overview.

Baron R, Harpaz I, Nemirovsky A, Cohen H, Monsonego A.

Exp Gerontol. 2007 Jan-Feb;42(1-2):64-9. Epub 2006 Oct 30. Review.

PMID:
17074458

Supplemental Content

Support Center